BackEndo International plc Overview
Endo International plc

Endo International plc Debt to Equity

Endo International plc (ENDP) has a debt-to-equity ratio of -2.52, below the Healthcare sector average of 0.3.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

-2.52

Debt to Equity

-2.52

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Endo International plc (ENDP) FAQ

The latest debt-to-equity ratio for ENDP is -2.52. That is below the Healthcare sector average of 0.3. Investors often review this figure alongside Endo International plc's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ENDP currently prints -2.52 for debt-to-equity ratio, while the sector average sits near 0.3. That is roughly 950.7% below the sector mean. Large gaps often invite a closer look at Endo International plc's growth, margins, and balance sheet.

A debt-to-equity ratio of -2.52 for Endo International plc is not 'good' or 'bad' on its own. Compare it with the peer average (0.3) and with ENDP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ENDP's debt-to-equity ratio (-2.52), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Endo International plc's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.